Ana Garrido-Castro

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Top Venues

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Fei Song, Paolo Tarantino, Ana Garrido-Castro, Filipa C Lynce, Sara M Tolaney, Ilana Schlam
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better? Current oncology reports 26 (1) (2024)
Fei Song, Paolo Tarantino, Ana Garrido-Castro, Filipa C Lynce, Sara M Tolaney, Ilana Schlam
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better? Current oncology reports 26 (1) (2024)
Fei Song, Paolo Tarantino, Ana Garrido-Castro, Filipa C Lynce, Sara M Tolaney, Ilana Schlam
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better? Current oncology reports (2024)
Fei Song, Paolo Tarantino, Ana Garrido-Castro, Filipa C Lynce, Sara M Tolaney, Ilana Schlam
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better? Current oncology reports 26 (1) (2024)
Fei Song, Paolo Tarantino, Ana Garrido-Castro, Filipa C Lynce, Sara M Tolaney, Ilana Schlam
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better? Current oncology reports 26 (1) (2024)
Fei Song, Paolo Tarantino, Ana Garrido-Castro, Filipa C Lynce, Sara M Tolaney, Ilana Schlam
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better? Current oncology reports 26 (1) (2024)
Fei Song, Paolo Tarantino, Ana Garrido-Castro, Filipa C Lynce, Sara M Tolaney, Ilana Schlam
Immunotherapy for Early-Stage Triple Negative Breast Cancer: Is Earlier Better? Current oncology reports 26 (1) (2024)